(Q72014999)
Statements
Epirubicin and medroxyprogesterone acetate versus estramustine phosphate in hormone-resistant prostatic cancer: a prospective randomized study (English)
Epirubicin and Medroxyprogesterone Acetate versus Estramustine Phosphate in Hormone-Resistant Prostatic Cancer: A Prospective Randomized Study (English)
1 reference
C. Anderström
A. Eddeland
P. Folmerz
R. Hansson
S. Milles